The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
World‐wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma
Open accessAbstract
Hepatitis B virus (HBV) and hepatitis C virus (HCV) are major causes of hepatocellular carcinoma (HCC). In order to assess the relative contribution of HBV and HCV to HCC worldwide, and identify changes over time, we conducted a systematic review of case series published up to the year 2014. Eligible studies had to report seroprevalence of both hepatitis B surface antigen (HBsAg) and antibodies to HCV (anti‐HCV), alone and in combination, for at least 20 adult HCC cases. Studies using a first‐generation enzyme‐linked immunosorbent assay test for HCV were excluded. A total of 119,000 HCC cases in 260 studies were included from 50 countries. Most European and American countries show a preponderance of HCV over HBV and a substantial fraction of viral marker–negative cases. Asian and African countries generally show a predominance of HBV. The fraction of HCV‐positive HCC cases is substantial in Taiwan, Mongolia, Japan, and Pakistan as well as in Western‐Central Asia and Northern Africa. No eligible studies were available in Oceania, large parts of Africa, Eastern Europe, and Central Asia. The United States, Brazil, and Germany show evidence of higher prevalence of HCV in HCC since the year 2000. Conversely, Japan and Italy show a decline in the proportion of HCV‐positive HCC. Conclusion: HBV and HCV are predominant causes of HCC in virtually all world areas, with a growing fraction of HCC cases in several countries attributable to HCV. (H epatology 2015;62:1190‐1200)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
El-Serag, H. B. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.12.061 · Cited by 3,380
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
Fattovich, G., Stroffolini, T., Zagni, I., & Donato, F. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.014 · Cited by 2,591
Global burden of cancers attributable to infections in 2008: a review and synthetic analysis
de Martel, C., Ferlay, J., Franceschi, S., Vignat, J., Bray, F., Forman, D., & Plummer, M. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70137-7 · Cited by 2,534
Self-citationMohd Hanafiah, K., Groeger, J., Flaxman, A. D., & Wiersma, S. T. (2013) · Hepatology · doi:10.1002/hep.26141 · Cited by 2,515
Bray, F., Jemal, A., Grey, N., Ferlay, J., & Forman, D. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70211-5 · Cited by 2,223
Global epidemiology and genotype distribution of the hepatitis C virus infection
Gower, E., Estes, C., Blach, S., Razavi-Shearer, K., & Razavi, H. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.07.027 · Cited by 1,903
Ott, J. J., Stevens, G. A., Groeger, J., & Wiersma, S. T. (2012) · Vaccine · doi:10.1016/j.vaccine.2011.12.116 · Cited by 1,843
Nelson, P. K., Mathers, B. M., Cowie, B., Hagan, H., Des Jarlais, D., Horyniak, D., & Degenhardt, L. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61097-0 · Cited by 1,267
Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis
Mokdad, A. A., Lopez, A. D., Shahraz, S., Lozano, R., Mokdad, A. H., Stanaway, J., Murray, C. J., & Naghavi, M. (2014) · BMC Medicine · doi:10.1186/s12916-014-0145-y · Cited by 1,129
Smith, B. D., Morgan, R. L., Beckett, G. A., Falck-Ytter, Y. T., Holtzman, D. J., Teo, C., Jewett, A., Baack, B. N., Rein, D. B., Patel, N., et al. (2012) · PubMed · Cited by 991
The Continuing Increase in the Incidence of Hepatocellular Carcinoma in the United States: An Update
El-Serag, H. B., Davila, J. A., Petersen, N. J., & McGlynn, K. A. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-10-200311180-00009 · Cited by 943
Human Development Report 2013. The Rise of the South: Human Progress in a Diverse WorldPreprint
Malik, K. (2013) · SSRN Electronic Journal · Cited by 768
Hahné, S. J., Veldhuijzen, I. K., Wiessing, L., Lim, T.-A., Salminen, M., & Laar, M. V. D. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-181 · Cited by 245
Raza, S. A., Clifford, G. M., & Franceschi, S. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603649 · Cited by 224
Self-citationA model of interaction: Aflatoxins and hepatitis viruses in liver cancer aetiology and prevention
Wild, C. P., & Montesano, R. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.02.053 · Cited by 185
Hepatitis Viruses, Alcohol, and Tobacco in the Etiology of Hepatocellular Carcinoma in Italy
Franceschi, S., Montella, M., Polesel, J., La Vecchia, C., Crispo, A., Dal Maso, L., Casarin, P., Izzo, F., Tommasi, L. G., Chemin, I., et al. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0702 · Cited by 162
Self-citationClinical guidelines on the management of hepatitis C
Booth, J. C. L., O'Grady, J., & Neuberger, J. (2001) · Gut · doi:10.1136/gut.49.suppl_1.i1 · Cited by 161
Shi, Y., Wu, Y. H., Wu, W., Zhang, W. J., Yang, J. J., & Chen, Z. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02481.x · Cited by 153
Wong, D. K.-H., Huang, F. Y., Lai, C., Poon, R. T. P., Seto, W., Fung, J., Hung, I. F., & Yuen, M. (2011) · Hepatology · doi:10.1002/hep.24551 · Cited by 152
Tang, C., Yau, T. O., & Yu, J. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i20.6262 · Cited by 137
Predicted Effects of Treatment for HCV Infection Vary Among European Countries
Deuffic‐Burban, S., Deltenre, P., Buti, M., Stroffolini, T., Parkes, J., Mühlberger, N., Siebert, U., Moreno, C., Hatzakis, A. E., Rosenberg, W. M., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.05.054 · Cited by 131
Tanaka, Y., Kurbanov, F., Mano, S., Orito, E., Vargas, V., Esteban, J. I., Yuen, M., Lai, C., Kramvis, A., Kew, M. C., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.032 · Cited by 128
Sun, Z., Chen, T., Thorgeirsson, S. S., Zhan, Q., Chen, J., Park, J., Lu, P., Hsia, C. C., Wang, N.-J., Xu, L., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt007 · Cited by 99
Treating Hepatitis C in Lower-Income Countries
Jayasekera, C. R., Barry, M., Roberts, L. R., & Nguyen, M. H. (2014) · New England Journal of Medicine · doi:10.1056/nejmp1400160 · Cited by 94
Liver cancer and hepatitis B and C in New South Wales, 1990–2002: a linkage study
Amin, J., O’Connell, D. L., Bartlett, M., Tracey, E. A., Kaldor, J. M., Law, M. G., & Dore, G. J. (2007) · Australian and New Zealand Journal of Public Health · doi:10.1111/j.1753-6405.2007.00121.x · Cited by 39
Shire, A. M., Sandhu, D. S., Kaiya, J. K., Oseini, A. M., Yang, J. D., Chaiteerakij, R., Mettler, T. A., Giama, N. H., Roberts, R. O., Therneau, T. M., et al. (2012) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2011.08.001 · Cited by 39
Qian, H., Zhong-min, Y., Shi, X., Gao, J., Xu, C., Wang, L., Zhou, K., Cui, Y., Zheng, X., Wu, Z., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/497148 · Cited by 23
Both HCV and HBV are Major Causes of Liver Cancer in Southeast Asians
Lin, H., Ha, N. B., Ahmed, A., Ayoub, W. S., Daugherty, T. J., Lutchman, G. A., García, G., & Nguyen, M. H. (2013) · Journal of Immigrant and Minority Health · doi:10.1007/s10903-013-9871-z · Cited by 18
Yip, D. (1999) · World Journal of Gastroenterology · doi:10.3748/wjg.v5.i6.483 · Cited by 17
Cited by
Burden of liver diseases in the world
Asrani, S. K., Devarbhavi, H., Eaton, J., & Kamath, P. S. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.09.014 · Cited by 3,783
Global burden of liver disease: 2023 update
Devarbhavi, H., Asrani, S. K., Arab, J. P., Nartey, Y. A., Pose, E., & Kamath, P. S. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.03.017 · Cited by 2,267
Omata, M., Cheng, A.-L., Kokudo, N., Kudo, M., Lee, J. M., Jia, J., Tateishi, R., Han, K.-H., Chawla, Y. K., Shiina, S., et al. (2017) · Hepatology International · doi:10.1007/s12072-017-9799-9 · Cited by 2,171
Global Burden of Disease Liver Cancer Collaboration, Akinyemiju, T., Abera, S., Ahmed, M., Alam, N., Alemayohu, M. A., Allen, C., Al-Raddadi, R., Alvis-Guzman, N., Amoako, Y., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2017.3055 · Cited by 1,987
Global burden of cancers attributable to infections in 2012: a synthetic analysis
Plummer, M., de Martel, C., Vignat, J., Ferlay, J., Bray, F., & Franceschi, S. (2016) · The Lancet Global Health · doi:10.1016/s2214-109x(16)30143-7 · Cited by 1,635
Self-citation
Metadata
- Authors
- de Martel, C., Maucort‐Boulch, D., Plummer, M., & Franceschi, S.
- Venue
- Hepatology
- Published
- 2015-09-29
- Volume
- 62
- Issue
- 4
- Pages
- 1190-1200
- ISSN
- 0270-9139 (ISSN-L)
- 1527-3350
- OpenAlex
- W1835730169
- Cited by
- 503
- References
- 30
- FWCI
- 32.11
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.